PHC Holdings Corporation

Based in Tokyo, Japan and established in 1969 as Matsushita Kotobuki Electronics Co. , Ltd. , PHC Holdings Corporation, also previously known as Panasonic Healthcare from 2010 to 2017, is a global healthcare company that engages in the development, manufacturing and provision of medical devices and other healthcare-related solutions. In 2012, the company acquired the healthcare business of Sanyo Electric Co.

, Ltd. , and the diabetes care business of Bayer AG in 2016 in order to establish its subsidiary Ascensia Diabetes Care. Later on, PHC established another subsidiary, Epredia, through the acquisition of the anatomical pathology business from Thermo Fisher Scientific, Inc. in 2019.

In addition, between 2019 and 2021, PHC acquired LSI Medience Corporation, SciMed (Asia) Pte Ltd, Amelieff Corporation, Fa-Tech Diagnostics and the electronic medical record business from Xirapha Karte System Co. , Ltd. PHC provides a variety of healthcare-related products and services, which can be divided into six categories: first, cancer pathology, which includes tissue processors, microscope slides and cytology staining solutions; second, biologic and cell preservation products, namely freezers, CO2 incubators, and automatic tablet counting and packaging systems; third, diagnostic testing services including clinical testing, diagnostic reagents and instruments; fourth, patient and record billing software, such as the Medicom-HRf electronic medical record system and the PharnesV-MX™ electronic medication history system; fifth, diabetes management solutions, for example, blood glucose monitoring systems and continuous glucose monitoring systems; lastly, medical device and drug delivery services.